Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions
Adult Primary Liver Cancer - Kidney Tumor
Conditions: official terms
Kidney Neoplasms - Liver Neoplasms
Study Type
Study Phase
Study Design
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Name: ultrasound elasticity imaging
Type: Procedure
Overall Status
This clinical trial studies ultrasound elastography in diagnosing patients with kidney or liver solid focal lesions. New diagnostic procedures, such as ultrasound elastography, may be a less invasive way to check for kidney or liver solid focal lesions.
Detailed Description

I. To determine the utility of ultrasound elastography in correlation with kidney or liver biopsy or magnetic resonance imaging (MRI) or computed tomography (CT) results.


Patients undergo ultrasound elastography.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 19 Years
Gender: Both
Criteria: Inclusion Criteria:

- There are no restrictions on life expectancy

- Eastern Cooperative Oncology Group (ECOG) or Karnofsky performance status will not be employed

- Patients of any ethnic background

- Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria:

- Patients should not be taking other investigational agents

- No requirements due to co-morbid disease or intercurrent illness, as needed

- No restrictions on allergic reactions as no imaging agent will be used

- Concomitant medications for treatment of the target lesion

- Pregnant or nursing patients will be excluded from the study
Stanford University Hospitals and Clinics
Stanford, California, United States
Status: Recruiting
Contact: Juergen Willmann - 650-725-1812 - willmann@stanford.edu
Start Date
January 2014
Stanford University
Stanford University
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page